Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- INDUSTRIAL SCIENCE & TECHNOLOGY NETWORK, INC.
- Proposal award date
- 2017-04-01
- Contract end date
- 2018-08-31
- UEI
- C3ZYYV7XVLA5
- Solicitation number
- PA15-269
- Topic code
- M
Research abstract
PROJECT SUMMARY
Over the last two decades the commercialization of silicone hydrogel andquot SiHyandquot composite technologies has led to new
soft CLs that are more breathable comfortable and affordable including in daily disposable versions which have
considerably broadened the customer base especially among younger generations Despite these improvements
the major persistent problem facing contact lenses is their poor compatibility with ocular environment particularly the
tear film While the softness of the new composite materials made lenses more comfortable by conforming better to
the cornea the resultant tight fitting considerably lowers the tear exchange rate in the post lens tear film In addition
the precision of lens design and fabrication limited by the difficulties of the thermal expansion of a dual domain silicon
and hydrogel substrate are adequate only for adjusting an imageandapos s focus not its visual acuity caused by other higher
order optical aberrations We propose to solve these issues by creating a novel contact lens material that will lead to
a new best in class soft lens with significant improvements in vision correction clarity and comfort and wide
applicability to numerous patient populations
This project will engineer the new generation of lens innovations based on several recent advances in material and
fabrication nanotechnologies The combined application of submicron morphology control molecular self assembly
and high precision molding as well as D printing will make future CL devices more precise biocompatible and
versatile We identified three major areas of improvement in CLs that will benefit from our implementation of such new
emerging technologies a Pre synthesis of new silicone block copolymers for higher precision control of domain
morphology during lens fabrication b Application of high precision fabrication and high definition andquot HDandquot design for
correcting the spherical aberration of CLs and c Engineering a novel design of lens material and surface coating for
enhancing PLTF turnover to improve ocular health
The new product would widely replace current CLs for at least the million patients in the US market and likely
expand this market significantly with new and valuable functions such as control of myopia progression for adolescents
and night vision enhancements for the elderly by high precision control and high definition design as well as
unprecedented comfort and biocompatibility by new surface coatingandapos s enhancement of PLTF turnover Further the
new level of comfort and extended wear time would solve one key challenge associated with current state of the art
in ocular drug delivery and monitoring devices promoting our technology to a future platform for growing these
applications to treat other large populations such as the million glaucoma patients worldwide PROJECT NARRATIVE
Soft contact lenses are an $ billion commercial market and worn by million people in the U S increase
from In addition to limitations in design precision that affect visual clarity of the lens a major related health
problem is lens biocompatibility which can lead to numerous patient complications and discomfort including notably
acanthamoeba keratitis $ million healthcare costs per year in the U S We propose to solve this problem by
developing an advanced silicone hydrogel SiHy contact lens with novel tear exchange mechanism and better visual
precision fully compatible with the ocular environment This new generation of materials will allow for extended wear
times beyond the current accepted modalities week monthly and create new opportunities for corrective
functions e g night vision enhancement myopia progression control as well as a future platform for commercially
viable ocular health monitoring and drug delivery lenses
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
13 SBIR/STTR records share this UEI (1997–2017). Reported award amounts total $5,134,830. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Energy
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards